Suppr超能文献

分析方法对纵向临床试验结果解读的影响。

The impact of analytic method on interpretation of outcomes in longitudinal clinical trials.

作者信息

Prakash A, Risser R C, Mallinckrodt C H

机构信息

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.

出版信息

Int J Clin Pract. 2008 Aug;62(8):1147-58. doi: 10.1111/j.1742-1241.2008.01808.x. Epub 2008 Jun 28.

Abstract

AIMS

Various analytical strategies for addressing missing data in clinical trials are utilised in reporting study results. The most commonly used analytical methods include the last observation carried forward (LOCF), observed case (OC) and the mixed model for repeated measures (MMRM). Each method requires certain assumptions regarding the characteristics of the missing data. If the assumptions for any particular method are not valid, results from that method can be biased. Results based on these different analytical methods can, therefore, be inconsistent, thereby making interpretation of clinical study results confusing. In this investigation, we compare results from MMRM, LOCF and OC in order to illustrate the potential biases and problems in interpretation.

METHODS

Data from an 8-month, double-blind, randomised, placebo-controlled (placebo; n = 137), outpatient depression clinical trial comparing a serotonin-noradrenalin reuptake inhibitor (SNRI; n = 273) with a selective serotonin reuptake inhibitor (SSRI; n = 274) were used. The study visit schedule included efficacy and safety assessments weekly to week 4, bi-weekly to week 8, and then monthly. Visitwise mean changes for the 17-item Hamilton Depression Rating Scale (HAMD(17)) Maier subscale (primary efficacy outcome), blood pressure, and body weight were analysed using LOCF, MMRM and OC.

RESULTS

Last observation carried forward consistently underestimated within-group mean changes in efficacy (benefit) and safety (risk) for both drugs compared with MMRM, whereas OC tended to overestimate within-group changes.

CONCLUSIONS

Inferences are based on between-group comparisons. Therefore, whether or not underestimating (overestimating) within-group changes was conservative or anticonservative depended on the relative magnitude of the bias in each treatment and on whether within-group changes represented improvement or worsening. Preference should be given in analytic plans to methods whose assumptions are more likely to be valid rather than relying on a method based on the hope that its results, if biased, will be conservative.

摘要

目的

在报告研究结果时会采用各种分析策略来处理临床试验中的缺失数据。最常用的分析方法包括末次观察结转(LOCF)、观察病例(OC)和重复测量混合模型(MMRM)。每种方法都需要对缺失数据的特征做出某些假设。如果任何特定方法的假设不成立,那么该方法得出的结果可能会有偏差。因此,基于这些不同分析方法得出的结果可能不一致,从而使临床研究结果的解读变得混乱。在本研究中,我们比较了MMRM、LOCF和OC的结果,以说明潜在的偏差和解读中的问题。

方法

使用了一项为期8个月的双盲、随机、安慰剂对照(安慰剂组;n = 137)门诊抑郁症临床试验的数据,该试验比较了一种5-羟色胺-去甲肾上腺素再摄取抑制剂(SNRI;n = 273)和一种选择性5-羟色胺再摄取抑制剂(SSRI;n = 274)。研究访视计划包括在第4周前每周、第4周至第8周每两周、之后每月进行疗效和安全性评估。使用LOCF、MMRM和OC分析了17项汉密尔顿抑郁量表(HAMD(17))迈尔子量表(主要疗效指标)、血压和体重的每次访视平均变化。

结果

与MMRM相比,末次观察结转始终低估了两种药物组内疗效(益处)和安全性(风险)的平均变化,而观察病例则倾向于高估组内变化。

结论

推断基于组间比较。因此,低估(高估)组内变化是保守还是反保守取决于每种治疗中偏差的相对大小以及组内变化代表的是改善还是恶化。在分析计划中应优先选择假设更可能成立的方法,而不是基于其结果即使有偏差也会是保守的这一希望而依赖某一种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a88/2658028/54edb59b91b1/ijcp0062-1147-f1.jpg

相似文献

1
The impact of analytic method on interpretation of outcomes in longitudinal clinical trials.
Int J Clin Pract. 2008 Aug;62(8):1147-58. doi: 10.1111/j.1742-1241.2008.01808.x. Epub 2008 Jun 28.
3
Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.
Adv Ther. 2011 Nov;28(11):1021-37. doi: 10.1007/s12325-011-0071-8. Epub 2011 Nov 2.

引用本文的文献

1
Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight.
Diabetes Obes Metab. 2025 May;27(5):2720-2729. doi: 10.1111/dom.16275. Epub 2025 Feb 25.
2
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
3
Estimands in published protocols of randomised trials: urgent improvement needed.
Trials. 2021 Oct 9;22(1):686. doi: 10.1186/s13063-021-05644-4.
5
When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
Brain Commun. 2020 Nov 18;3(1):fcaa201. doi: 10.1093/braincomms/fcaa201. eCollection 2021.
7
Dose-Response Mixed Models for Repeated Measures - a New Method for Assessment of Dose-Response.
Pharm Res. 2020 Jul 31;37(8):157. doi: 10.1007/s11095-020-02882-0.

本文引用的文献

2
Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Clin Drug Investig. 2007;27(7):481-92. doi: 10.2165/00044011-200727070-00005.
4
Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Curr Med Res Opin. 2007 Jun;23(6):1303-18. doi: 10.1185/030079907X188107. Epub 2007 Apr 27.
6
Psychiatric diagnosis and clinical trial completion rates: analysis of the FDA SBA reports.
Neuropsychopharmacology. 2007 Nov;32(11):2422-30. doi: 10.1038/sj.npp.1301361. Epub 2007 Feb 21.
9
Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology.
Biol Psychiatry. 2006 Jun 1;59(11):1001-5. doi: 10.1016/j.biopsych.2005.10.020. Epub 2006 Feb 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验